Avicanna Inc has recently launched a healthcare initiative and is navigating a challenging market landscape.
This week, Avicanna Inc (AVCN.TO) remains steady at C$0.10, showing no change from the previous trading day. Despite recent developments in the healthcare sector, the stock has faced a notable decline over the past month, down 19.23%. Investors are closely watching the company’s progress as it seeks to integrate medical cannabis into Canadian healthcare systems.
Investor takeaway: Avicanna's recent initiatives may position it for future growth, but investors should be aware of the current bearish trend and the company's financial challenges.
Advertisement
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$14.11M
52W high
$0.30
52W low
$0.10
1W change
+0.00%
Beta
0.34
Analyst Price Targets
Based on analyst covering AVCN · as of Sep 17, 2026
Wall Street analysts forecast AVCN stock price to rise 566.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+566.7% Upside
Current Price
C$0.10
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
91.8%
Annualized
90-Day Vol
78.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.10 | C$0.07 – C$0.14 |
| 60 trading days | C$0.09 | C$0.06 – C$0.15 |
| 90 trading days | C$0.09 | C$0.05 – C$0.15 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Avicanna's Stock Down 52.27% Year-to-Date
The stock has traded within a narrow range of C$0.10 to C$0.30 over the past year, reflecting ongoing volatility and investor uncertainty.
Bull case
The launch of the MyMedi.ca Integrated Healthcare Program could boost Avicanna's visibility and credibility in the healthcare sector. This might lead to greater acceptance and adoption of its products in the market.
Bear case
However, with a significant drop in stock price over the past year and low trading volume compared to its average, investors may remain cautious about Avicanna's financial health and overall market position.
Recent Developments
Avicanna recently launched the MyMedi.ca Integrated Healthcare Program, aiming to integrate medical cannabis care into Canadian healthcare institutions. This initiative, announced on September 9, 2026, could provide a framework for enhancing the accessibility and acceptance of medical cannabis in clinical settings.
Advertisement
Technical Picture
Avicanna's stock closed at C$0.10, with a 52-week range of C$0.10 to C$0.30, indicating it is currently at the lower end of this range. The stock is trading below both its 50-day moving average of C$0.12 and its 200-day moving average of C$0.16, reflecting a downtrend. The stock has a beta of 0.34, suggesting lower volatility compared to the market. With a recent trading volume of 2,800 shares, this is significantly lower than the 20-day average volume of 155,743 shares, indicating reduced trading activity.
Insider Activity
No recent insider activity has been reported for Avicanna Inc, which may suggest a lack of immediate confidence or concern among insiders regarding the company’s future prospects.
Market Performance
Year-to-date, Avicanna has seen a decline of 52.27%. While the average analyst target stands at C$0.70, implying a potential upside of 566.7%, the current financial metrics, including a profit margin of -14.8% and a return on equity of -30.0%, may raise concerns for cautious investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
